Anavex Life Sciences Corp (AVXL)

[makemydaze]

If Ariana is/was able to identify a trend using the data collected from the 32 Alz patients will that translate into identifying a subset of people that will benefit the most from 2-73 irregardless of their disease?

For example the following statement makes it seem (to me) that the 32 Alz patient data would assist in a Parkinsons trial also -

"Anavex’s 32-patient Alzheimer’s study utilizing KEM® will enable systematic analysis of more data on each patient in the disease group, on par with similar studies of significantly larger size, while providing greater cost and time efficiency."

“The ongoing Phase 2a Alzheimer’s clinical trial was specifically designed to learn as much as possible about ANAVEX 2-73 in order to optimize trial parameters for future pivotal trials and potentially reduce the risk of failure in a later, larger Phase 2/3 study and in a planned Parkinson’s Phase 2 study. We believe that the collaboration with Ariana Pharma will potentially accelerate the development process,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

http://www.arianapharma.com/2016/10/anavex-life-sciences-and-ariana-pharma-collaborate-to-accelerate-timelines-and-improve-efficiency-of-alzheimers-and-parkinsons-clinical-development-programs/